According to Contineum Therapeutics's latest financial reports the company has C$0.30 Billion in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-12-31 | C$0.16 B | 159.04% |
2022-12-31 | C$64.1 M | -27.11% |
2021-12-31 | C$87.94 M |